Acalabrutinib and its Impurities
Acalabrutinib is used to treat certain types of cancer. It is a second generation Bruton's tyrosine kinase inhibitor.Reference standards of Acalabrutinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
 
	
			                                   
																				4-(8-Amino-3-(4-(but-2-ynamido)butanoyl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
4-(8-Amino-3-(4-(but-2-ynamido)butanoyl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 50510 
- CAS : - 2230757-47-6
- Molecular Formula : C26H23N7O3 
- Molecular Weight : 481.52 
 
	
			                                   
																				(2R)-2-Amino-3-[(E)-3-[(2S)-2-[8-amino-1-[4-(2-pyridylcarbamoyl)phenyl]imidazo [1,5-a]pyrazin-3-yl]pyrrolidin-1-yl]-1-methyl-3-oxo-prop-1-enyl]sulfanyl-propanoic acid
(2R)-2-Amino-3-[(E)-3-[(2S)-2-[8-amino-1-[4-(2-pyridylcarbamoyl)phenyl]imidazo [1,5-a]pyrazin-3-yl]pyrrolidin-1-yl]-1-methyl-3-oxo-prop-1-enyl]sulfanyl-propanoic acid
- Catalogue No.:PA 54 0501002 
- CAS : - NA
- Molecular Formula : C29H30N8O4S 
- Molecular Weight : 586.67 
 
	
			                                   
																				4-[8-Amino-3-[(2S)-1-(3-oxobutanoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-(2-pyridyl)benzamide
4-[8-Amino-3-[(2S)-1-(3-oxobutanoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-(2-pyridyl)benzamide
- Catalogue No.:PA 54 0501003 
- CAS : - NA
- Molecular Formula : C26H25N7O3 
- Molecular Weight : 483.53 
 
	
			                                   
																				(S)-4-(9-(1-(But-2-ynoyl)pyrrolidin-2-yl)-4-methyl-2-oxo-2H-imidazo[5',1':3,4]pyrazino[1,2-a]pyrimidin-11-yl)-N-(pyridin-2-yl)benzamide
(S)-4-(9-(1-(But-2-ynoyl)pyrrolidin-2-yl)-4-methyl-2-oxo-2H-imidazo[5',1':3,4]pyrazino[1,2-a]pyrimidin-11-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 0501007 
- CAS : - 2490433-97-9
- Molecular Formula : C30H25N7O3 
- Molecular Weight : 531.58 
 
	
			                                   
																				4-(8-((4-((S)-2-(8-Amino-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazin-3-yl)pyrrolidin-1-yl)-4-oxobut-2-en-2-yl)amino)-3-((S)-1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
4-(8-((4-((S)-2-(8-Amino-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazin-3-yl)pyrrolidin-1-yl)-4-oxobut-2-en-2-yl)amino)-3-((S)-1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 0501008 
- CAS : - NA
- Molecular Formula : C52H46N14O4 
- Molecular Weight : 931.03 
 
	
			                                   
																				(S)-4-(9-(1-(But-2-ynoyl)pyrrolidin-2-yl)-2-methyl-4-oxo-4H-imidazo[5',1':3,4]pyrazino[1,2-a]pyrimidin-11-yl)-N-(pyridin-2-yl)benzamide
(S)-4-(9-(1-(But-2-ynoyl)pyrrolidin-2-yl)-2-methyl-4-oxo-4H-imidazo[5',1':3,4]pyrazino[1,2-a]pyrimidin-11-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 0501013 
- CAS : - 2412166-56-2
- Molecular Formula : C30H25N7O3 
- Molecular Weight : 531.58 
 
	
			                                   
																				(S)-8-Amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazine 7-Oxide
(S)-8-Amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazine 7-Oxide
- Catalogue No.:PA 54 0501018 
- CAS : - NA
- Molecular Formula : C26H23N7O3 
- Molecular Weight : 481.52 
 
	
			                                   
																				(S)-2-(4-(8-Amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)benzamido)pyridine 1-Oxide
(S)-2-(4-(8-Amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)benzamido)pyridine 1-Oxide
- Catalogue No.:PA 54 0501019 
- CAS : - NA
- Molecular Formula : C26H23N7O3 
- Molecular Weight : 481.52 
 
	
			                                   
																				(S)-4-(8-Amino-3-(1-nitrosopyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
(S)-4-(8-Amino-3-(1-nitrosopyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 0501020 
- CAS : - NA
- Molecular Formula : C22H20N8O2 
- Molecular Weight : 428.46 
 
	
			                                   
																				4-(8-Amino-3-(3,4-dihydro-2H-pyrrol-5-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
4-(8-Amino-3-(3,4-dihydro-2H-pyrrol-5-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 0501034 
- CAS : - 2230757-49-8
- Molecular Formula : C22H19N7O 
- Molecular Weight : 397.44 
 
	
			                                   
																				4,4'-(((2S,2'S)-(1-Oxobut-2-ene-1,3-diyl)bis(pyrrolidine-1,2-diyl))bis(8-aminoimidazo[1,5-a]pyrazine-3,1-diyl))bis(N-(pyridin-2-yl)benzamide)
4,4'-(((2S,2'S)-(1-Oxobut-2-ene-1,3-diyl)bis(pyrrolidine-1,2-diyl))bis(8-aminoimidazo[1,5-a]pyrazine-3,1-diyl))bis(N-(pyridin-2-yl)benzamide)
- Catalogue No.:PA 54 0501043 
- CAS : - NA
- Molecular Formula : C48H44N14O3 
- Molecular Weight : 864.98 
 
	
			                                   
																				4,4'-(((2R,2'R)-Methylenebis(pyrrolidine-1,2-diyl))bis(8-aminoimidazo[1,5-a]pyrazine-3,1-diyl))bis(N-(pyridin-2-yl)benzamide)
4,4'-(((2R,2'R)-Methylenebis(pyrrolidine-1,2-diyl))bis(8-aminoimidazo[1,5-a]pyrazine-3,1-diyl))bis(N-(pyridin-2-yl)benzamide)
- Catalogue No.:PA 54 0501044 
- CAS : - NA
- Molecular Formula : C45H42N14O2 
- Molecular Weight : 810.93 
 
	
			                                   
																				(S,Z)-4-(8-Amino-3-(1-(3-bromobut-2-enoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
(S,Z)-4-(8-Amino-3-(1-(3-bromobut-2-enoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 0501045 
- CAS : - NA
- Molecular Formula : C26H24BrN7O2 
- Molecular Weight : 546.43 
 
	
			                                   
																				4-(7-((Z)-4-((S)-2-(8-Amino-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazin-3-yl)pyrrolidin-1-yl)-4-oxobut-2-en-2-yl)-3-((S)-1-(but-2-ynoyl)pyrrolidin-2-yl)-8-imino-7,8-dihydroimidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
4-(7-((Z)-4-((S)-2-(8-Amino-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazin-3-yl)pyrrolidin-1-yl)-4-oxobut-2-en-2-yl)-3-((S)-1-(but-2-ynoyl)pyrrolidin-2-yl)-8-imino-7,8-dihydroimidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 0501046 
- CAS : - NA
- Molecular Formula : C52H46N14O4 
- Molecular Weight : 931.03 
 
	
			                                   
																				4-(8-(((E)-4-((R)-2-(8-Amino-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazin-3-yl)pyrrolidin-1-yl)-4-oxobut-2-en-2-yl)amino)-3-((S)-1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
4-(8-(((E)-4-((R)-2-(8-Amino-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazin-3-yl)pyrrolidin-1-yl)-4-oxobut-2-en-2-yl)amino)-3-((S)-1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- Catalogue No.:PA 54 0501047 
- CAS : - NA
- Molecular Formula : C52H46N14O4 
- Molecular Weight : 931.03 

 
																				![Benzyl (S)-2-(8-amino-6-bromoimidazo[1,5-a]pyrazin PA 54 0501000](https://www.pharmaffiliates.com/pimages/PA540501000.jpg) 
																				![Benzyl (S)-2-(8-amino-5-bromoimidazo[1,5-a]pyrazin PA 54 0501001](https://www.pharmaffiliates.com/pimages/PA540501001.jpg) 
																				 
																				 
																				![(4-[8-Amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]i PA 54 0501006](https://www.pharmaffiliates.com/pimages/PA540501006.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				![Benzyl 2-(1-bromo-8-hydroxyimidazo[1,5-a]pyrazin-3 PA 54 0501015](https://www.pharmaffiliates.com/pimages/PA540501015.jpg) 
																				![Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-y PA 54 0501016](https://www.pharmaffiliates.com/pimages/PA540501016.jpg) 
																				![N4,N4'-Di(pyridin-2-yl)-[1,1'-biphenyl]-4,4'-dicar PA 54 0501017](https://www.pharmaffiliates.com/pimages/PA540501017.jpg) 
																				 
																				 
																				![(S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]py PA 54 0501023](https://www.pharmaffiliates.com/pimages/PA540501023.jpg) 
																				![Benzyl (S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin PA 54 0501024](https://www.pharmaffiliates.com/pimages/PA540501024.jpg) 
																				 
																				![Benzyl (S)-2-(8-chloroimidazo[1,5-a]pyrazin-3-yl)p PA 54 0501026](https://www.pharmaffiliates.com/pimages/PA540501026.jpg) 
																				![Benzyl (S)-2-(1-bromo-8-chloroimidazo[1,5-a]pyrazi PA 54 0501027](https://www.pharmaffiliates.com/pimages/PA540501027.jpg) 
																				![Benzyl (R)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin PA 54 0501028](https://www.pharmaffiliates.com/pimages/PA540501028.jpg) 
																				![Benzyl (S)-2-(8-aminoimidazo[1,5-a]pyrazin-3-yl)py PA 54 0501029](https://www.pharmaffiliates.com/pimages/PA540501029.jpg) 
																				 
																				 
																				 
																				 
																				![(S)-1-bromo-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyraz PA 54 0501033](https://www.pharmaffiliates.com/pimages/PA540501033.jpg) 
																				 
																				 
																				![Benzyl (S)-2-(8-amino-1,6-dibromoimidazo[1,5-a]pyr PA 54 0501037](https://www.pharmaffiliates.com/pimages/PA540501037.jpg) 
																				![Benzyl (S)-2-(8-amino-1,5-dibromoimidazo[1,5-a]pyr PA 54 0501038](https://www.pharmaffiliates.com/pimages/PA540501038.jpg) 
																				 
																				 
																				 
																				 
																				 
 
 
 
